logo
Scientists make concerning discovering about hidden dangers lurking in recycling bins: 'This is the main obstacle'

Scientists make concerning discovering about hidden dangers lurking in recycling bins: 'This is the main obstacle'

Yahoo19-07-2025
Scientists make concerning discovering about hidden dangers lurking in recycling bins: 'This is the main obstacle'
Recycling is a core defense against plastic pollution, but that does not mean it is a perfect solution.
In fact, a team led by researchers from the University of Gothenburg found some real concerns lurking within recycled plastics. Addressing them is crucial to fulfill the potential of recycling, according to the school's press release.
What's happening?
To understand global plastic waste better, the scientists collected samples of recycled polyethylene plastic from various parts of the world. They let them soak in water for two days, and when they analyzed the water afterward, they found over 80 different chemicals leached from the plastic.
Some were expected ingredients, but others were not supposed to be there, like pesticides, pharmaceuticals, and other toxic substances. These harmful compounds are often added to plastic but are not declared. Some may have also tainted the plastic during its life before it was recycled, the press release explained.
Sounds nasty? Unfortunately, there's more.
The aim of the new study was to explore the consequences of ingesting all of those chemicals on living organisms. The researchers put zebrafish larvae in the contaminated water for five days. That brief exposure was all it took to disrupt the organisms' hormones and metabolism, per the university.
"This is the main obstacle with the idea of recycling plastic," Bethanie Carney Almroth, professor at the University of Gothenburg and project lead, said in a statement. "We never have full knowledge of what chemicals will end up in an item."
Why is contaminated recycling important?
The prevalence of plastic products in everyday human life was already a concern. Prior research shows that as they slowly break down, they wind up in the environment and our bodies, where they pose serious health risks.
The research team's findings offer more evidence of why this plastic is so dangerous, even after it has been recycled. Much like the zebrafish in the study, exposure to the toxic chemicals they found also poses risks to humans' hormones, reproductive health, and metabolism, per the press release.
"This work clearly demonstrates the need to address toxic chemicals in plastics materials and products, across their life cycle," Almroth affirmed in the statement.
Do you worry about having toxic forever chemicals in your home?
Majorly
Sometimes
Not really
I don't know enough about them
Click your choice to see results and speak your mind.
What's being done to clean up plastic recycling?
A global plastics treaty is in the works as a result of United Nations efforts. The presence of toxic chemicals in plastics and the lack of transparency in production lines are priorities in the negotiations.
However, you do not need to wait for regulators and politicians to start minimizing your plastic use. Making easy switches from single-use products to reusable ones can save money and help you avoid some of the scary things that end up hiding in plastics.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Clinical Evaluation of Medical Devices: The Clinical Evaluation Report (2-Day Online Training Course with 12 CPD Hours: November 25-26, 2025)
Clinical Evaluation of Medical Devices: The Clinical Evaluation Report (2-Day Online Training Course with 12 CPD Hours: November 25-26, 2025)

Yahoo

timean hour ago

  • Yahoo

Clinical Evaluation of Medical Devices: The Clinical Evaluation Report (2-Day Online Training Course with 12 CPD Hours: November 25-26, 2025)

Join this comprehensive course on clinical evaluation aligned with European MDR, offering tools to craft high-quality Clinical Evaluation Reports (CER) for medical devices. Gain expertise in data collection, analysis, and regulatory compliance. Includes case studies and templates. Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Clinical Evaluation of Medical Devices: The Clinical Evaluation Report Training Course" has been added to offering. This introductory course will cover all aspects of clinical evaluation in line with the European Medical Device Regulation (MDR) and applicable guidance documents. The programme will provide you with the tools and skills you will need to produce a high-quality clinical evaluation report (CER) for all your medical devices. You will understand the detail of what clinical data is needed, how to collect it, analyse it and receive direction on producing a CER that is acceptable to the regulatory authorities and Notified Bodies. You will learn how the process fits into the development of a medical device and also the post-market aspects of clinical evidence. The programme includes case studies and template documents which you will be able to utilise to produce your own clinical data evidence documentation. Benefits of attending: Gain a detailed overview of the clinical evaluation process Understand the concepts involved in conducting a clinical evaluation Learn how to utilise information gathered during a clinical evaluation Take away skills in conducting systematic literature searches Understand where clinical evaluation fits into the development and marketing of medical devices Explore how to appraise data Know how to assemble clinical evidence acceptable for review by regulatory authorities or Notified Bodies Certifications: CPD: 12 hours for your records Certificate of completion Who Should Attend: CROs Medical writers Clinical staff Those who conduct clinical evaluations/investigations/post-market follow-up studies Those moving from pharmaceuticals to medical devices And personnel involved in: Gathering clinical evidence and conducting clinical evaluations R&D Regulatory affairs Key Topics Covered What is a clinical evaluation? Explanation of the terminology used in clinical evaluations Overview of a clinical evaluation The importance of clinical evidence in medical device development Why and when is it necessary to conduct a clinical evaluation? Where does clinical evaluation sit within the medical device process? Why is clinical evidence important? Who are the stakeholders in the process? Who and what is involved in the clinical evaluation process? Overview of each step Use of equivalent products Workshop: bringing it together An interactive exercise on what has been learnt so far What regulations govern clinical evaluations and what guidance documents should clinical evaluations be conducted to? An in-depth review of the available regulatory and guidance documents which can be utilised during the process and how to interpret these Documentation necessary for conducting a clinical evaluation The clinical evaluation plan The literature review process Selecting databases and conducting searches How to source data and review it How to clarify the question on which you need to find literature, including devising the most comprehensive literature search strategy and selecting keywords The Clinical Evaluation Report (CER) What is it and what is included? Who should write it? How to write it What is state of the art and how to conduct a risk benefit assessment of the data? Performance and safety analysis State-of-the-art analysis Risk-benefit analysis Impact of the Medical Device Regulations (MDR) For more information about this training visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Ovarian Cancer Risk Rises Soon After IBS Diagnosis
Ovarian Cancer Risk Rises Soon After IBS Diagnosis

Medscape

timean hour ago

  • Medscape

Ovarian Cancer Risk Rises Soon After IBS Diagnosis

TOPLINE: Women with a new diagnosis of irritable bowel syndrome (IBS) have a significantly higher risk for ovarian cancer at 3 months and 6 months post-diagnosis, but this risk is no longer elevated beyond 8 months. METHODOLOGY: Ovarian cancer often presents with nonspecific symptoms overlapping those of IBS. The frequency of misdiagnosis remains unknown, and not all IBS guidelines recommend screening for ovarian cancer. Researchers conducted a retrospective cohort study using US administrative claims data to compare ovarian cancer incidence in adult women with and without a new IBS diagnosis. Diagnostic codes were used to identify cases of IBS and ovarian cancer. TAKEAWAY: The cohort comprised 9804 women with IBS and 79,804 women without IBS, identified between January 2017 and December 2020. Women with IBS had a significantly higher risk for ovarian cancer at 3 months (hazard ratio [HR], 1.71; P = .02) and 6 months (HR, 1.43; P = .02), but not beyond 8 months post-diagnosis. Women with both IBS and endometriosis had an even greater risk for ovarian cancer at 3 months (HR, 4.20; P = .01), 6 months (HR, 3.52; P = .01), and after 1 year (HR, 2.67; P = .04). Increasing age was significantly associated with higher ovarian cancer incidence only in women younger than 50 years (HR, 1.07; P < .01), regardless of IBS status. IN PRACTICE: 'Identifying patient-specific risk factors, such as chronic pelvic pain or endometriosis, could help develop tailored risk profiles and improve the approach to personalized care in women with IBS-type symptoms,' the authors wrote. SOURCE: This study was led by Andrea Shin, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles. It was published online in Alimentary Pharmacology & Therapeutics. LIMITATIONS: The use of diagnostic codes for identifying IBS may have led to misclassification or reflected symptoms rather than confirmed and validated diagnosis. DISCLOSURES: This study received support from the National Institutes of Health. Some authors reported serving as consultants, advisors, and/or receiving research support from pharmaceutical and healthcare companies; one author reported having stock options. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Trump's Hand Makeup Reappears on Overseas Trip to Scotland
Trump's Hand Makeup Reappears on Overseas Trip to Scotland

Yahoo

timean hour ago

  • Yahoo

Trump's Hand Makeup Reappears on Overseas Trip to Scotland

President Trump has packed his faithful supply of hand make-up for his trip to Scotland. Photographs of Trump meeting European Commission President Ursula von der Leyen on Sunday reveal the persistent bruising on his right hand continues to be covered with heavy concealer. The president was announcing a trade deal between the U.S. and Europe when cameras panned to his hand. The White House referred the Daily Beast to a July 17 medical report that diagnosed the president with chronic venous insufficiency, saying it was a benign and common condition, particularly in individuals over the age of 70. The White House also referred to Press Secretary Karoline Leavitt's remarks that, 'The president remains in excellent health.' The bruising on his hand was particularly visible as the president spoke to the media on the South Lawn on the White House on Friday before he departed for Scotland on Marine One. The mysterious ailment on Trump's hand made news in February when the large bruise was noticed during French President Emmanuel Macron's visit to the White House. It has become a talking point ever since. It was also spotted last Thursday during Trump's visit to the Federal Reserve headquarters on Thursday. The bruise was later explained as being a byproduct of hand-shaking by the White House. Leavitt told the Daily Beast earlier this month that Trump is 'a man of the people and he meets more Americans and shakes their hands on a daily basis than any other president in history.' Last week, Leavitt produced a letter from the White House physician to address the issue of Trump's swelling and bruising, confirming Trump had been seen for a check-up. The 'comprehensive examination' of the 79-year-old concluded he had Chronic Venous Insufficiency (CVI), which occurs when the veins cannot manage blood flow well, making it hard for the blood to return to the heart. Physician Sean Barbabella said in his report, 'Recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen.' He added, 'This is a well-known and benign side effect of aspirin therapy.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store